122 related articles for article (PubMed ID: 37591406)
1. Lipodystrophic gene Agpat2 deficiency aggravates hyperlipidemia and atherosclerosis in Ldlr
Peng K; Chen X; Pei K; Wang X; Ma X; Liang C; Dong Q; Liu Z; Han M; Liu G; Yang H; Zheng M; Liu G; Gao M
Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166850. PubMed ID: 37591406
[TBL] [Abstract][Full Text] [Related]
2. Adipose tissue deficiency results in severe hyperlipidemia and atherosclerosis in the low-density lipoprotein receptor knockout mice.
Wang M; Gao M; Liao J; Qi Y; Du X; Wang Y; Li L; Liu G; Yang H
Biochim Biophys Acta; 2016 May; 1861(5):410-8. PubMed ID: 26921684
[TBL] [Abstract][Full Text] [Related]
3. Obesity potentiates development of fatty liver and insulin resistance, but not atherosclerosis, in high-fat diet-fed agouti LDLR-deficient mice.
Coenen KR; Hasty AH
Am J Physiol Endocrinol Metab; 2007 Aug; 293(2):E492-9. PubMed ID: 17566116
[TBL] [Abstract][Full Text] [Related]
4. Hyperlipidemia induces typical atherosclerosis development in Ldlr and Apoe deficient rats.
Zhao Y; Yang Y; Xing R; Cui X; Xiao Y; Xie L; You P; Wang T; Zeng L; Peng W; Li D; Chen H; Liu M
Atherosclerosis; 2018 Apr; 271():26-35. PubMed ID: 29459263
[TBL] [Abstract][Full Text] [Related]
5. Group 1B phospholipase A₂ inactivation suppresses atherosclerosis and metabolic diseases in LDL receptor-deficient mice.
Hollie NI; Konaniah ES; Goodin C; Hui DY
Atherosclerosis; 2014 Jun; 234(2):377-80. PubMed ID: 24747111
[TBL] [Abstract][Full Text] [Related]
6. Surgical fat removal exacerbates metabolic disorders but not atherogenesis in LDLR
Liu L; Liang C; Wang X; Ding X; Lu Y; Dong J; Han M; Yang H; Gao M; Liao J
Sci Rep; 2019 Nov; 9(1):17848. PubMed ID: 31780791
[TBL] [Abstract][Full Text] [Related]
7. Dyslipidemia, steatohepatitis and atherogenesis in lipodystrophic apoE deficient mice with Seipin deletion.
Liao J; Liu X; Gao M; Wang M; Wang Y; Wang F; Huang W; Liu G
Gene; 2018 Mar; 648():82-88. PubMed ID: 29428127
[TBL] [Abstract][Full Text] [Related]
8. Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice.
Hasan ST; Zingg JM; Kwan P; Noble T; Smith D; Meydani M
Atherosclerosis; 2014 Jan; 232(1):40-51. PubMed ID: 24401215
[TBL] [Abstract][Full Text] [Related]
9. Loss of Transcription Factor CREBH Accelerates Diet-Induced Atherosclerosis in Ldlr-/- Mice.
Park JG; Xu X; Cho S; Lee AH
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1772-81. PubMed ID: 27417587
[TBL] [Abstract][Full Text] [Related]
10.
Arndt L; Hernandez-Resendiz I; Moos D; Dokas J; Müller S; Jeromin F; Wagner R; Ceglarek U; Heid IM; Höring M; Liebisch G; Stadler SC; Burkhardt R
Arterioscler Thromb Vasc Biol; 2023 Jun; 43(6):979-994. PubMed ID: 37078290
[TBL] [Abstract][Full Text] [Related]
11. High fat / high cholesterol diet does not provoke atherosclerosis in the ω3-and ω6-polyunsaturated fatty acid synthesis-inactivated Δ6-fatty acid desaturase-deficient mouse.
Stoffel W; Binczek E; Schmidt-Soltau I; Brodesser S; Wegner I
Mol Metab; 2021 Dec; 54():101335. PubMed ID: 34530175
[TBL] [Abstract][Full Text] [Related]
12. Transgenic mice express human MPO -463G/A alleles at atherosclerotic lesions, developing hyperlipidemia and obesity in -463G males.
Castellani LW; Chang JJ; Wang X; Lusis AJ; Reynolds WF
J Lipid Res; 2006 Jul; 47(7):1366-77. PubMed ID: 16639078
[TBL] [Abstract][Full Text] [Related]
13. Adipose transplantation improves metabolism and atherosclerosis but not perivascular adipose tissue abnormality or vascular dysfunction in lipodystrophic
Meng Z; Liu C; Xu M; Tao Y; Li H; Wang X; Liao J; Wang M
Am J Physiol Cell Physiol; 2024 May; 326(5):C1410-C1422. PubMed ID: 38525541
[TBL] [Abstract][Full Text] [Related]
14. Deficiency of Invariant Natural Killer T Cells Does Not Protect Against Obesity but Exacerbates Atherosclerosis in Ldlr
Subramanian S; Goodspeed L; Wang S; Ding Y; O'Brien KD; Getz GS; Chait A; Reardon CA
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29419749
[TBL] [Abstract][Full Text] [Related]
15. Leptin ameliorates insulin resistance and hepatic steatosis in Agpat2-/- lipodystrophic mice independent of hepatocyte leptin receptors.
Cortés VA; Cautivo KM; Rong S; Garg A; Horton JD; Agarwal AK
J Lipid Res; 2014 Feb; 55(2):276-88. PubMed ID: 24293639
[TBL] [Abstract][Full Text] [Related]
16. Hyperlipidemia and atherosclerotic lesion development in Ldlr-deficient mice on a long-term high-fat diet.
Ma Y; Wang W; Zhang J; Lu Y; Wu W; Yan H; Wang Y
PLoS One; 2012; 7(4):e35835. PubMed ID: 22558236
[TBL] [Abstract][Full Text] [Related]
17. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ
Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172
[TBL] [Abstract][Full Text] [Related]
18. Hepatic NPC1L1 promotes hyperlipidemia in LDL receptor deficient mice.
Wang Y; Tang W; Yang P; Shin H; Li Q
Biochem Biophys Res Commun; 2018 May; 499(3):626-633. PubMed ID: 29601818
[TBL] [Abstract][Full Text] [Related]
19. Carbenoxolone treatment attenuates symptoms of metabolic syndrome and atherogenesis in obese, hyperlipidemic mice.
Nuotio-Antar AM; Hachey DL; Hasty AH
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1517-28. PubMed ID: 17878220
[TBL] [Abstract][Full Text] [Related]
20. Effects of High Fat Feeding and Diabetes on Regression of Atherosclerosis Induced by Low-Density Lipoprotein Receptor Gene Therapy in LDL Receptor-Deficient Mice.
Willecke F; Yuan C; Oka K; Chan L; Hu Y; Barnhart S; Bornfeldt KE; Goldberg IJ; Fisher EA
PLoS One; 2015; 10(6):e0128996. PubMed ID: 26046657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
